outcomes research

Research in Review

Clinical Trials Improve Survival, Lower Costs for Patients With Cancer

06/27/2017

JCP Editors

Clinical trial participation for patients with cancer often result in measurable benefits, including lowered costs and extended survival. ----- Related Content Trial Shows Precision Medicine Improves Cancer...

...

06/27/2017

Journal of Clinical Pathways

Research in Review

Cost-Effective Substitute for Breast Cancer MRI Identified

06/26/2017

JCP Editors

A recent analysis reports a cost-effective alternative modality that demonstrates similar efficacy to traditional breast magnetic resonance imaging (MRI), published in the American Journal of Roentgenology (June...

A...

06/26/2017

Journal of Clinical Pathways

Research in Review

Novel Prognostic Biomarker Identified in DLBCL

06/23/2017

JCP Editors

A new prognostic indicator involving monocytes has been identified for patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL), according to research presented at the 22nd Congress of the European...

A new...

06/23/2017

Journal of Clinical Pathways

Research in Review

Prognostic Tools Identify High-Risk Patients With Multiple Myeloma, Predict Survival

06/22/2017

JCP Editors

Multiple prognostic tools help risk stratify older patients with multiple myeloma and predict treatment-specific survival, according to data that will be presented at the 22nd Congress of the European Hematology...

...

06/22/2017

Journal of Clinical Pathways

Research in Review

High-Dose Chemo Yields Similar Survival Outcomes in Patients With AML

06/22/2017

JCP Editors

Standard induction chemotherapy is noninferior to high-dose chemotherapy in patients with newly diagnosed acute myeloid leukemia (AML), according to new research published in the Journal of Clinical Oncology...

...

06/22/2017

Journal of Clinical Pathways

Research in Review

Biomarker Associated With Worse Survival Outcomes in Ovarian Cancer

06/20/2017

JCP Editors

Women with advanced ovarian cancer who express a certain tumor antigen will likely experience a shorter progression-free survival (PFS) and overall survival (OS) than those without the antigen, according to research...

Women...

06/20/2017

Journal of Clinical Pathways

Research in Review

RA Relapse Prediction Tool Decreases Cost of Treatment

06/19/2017

JCP Editors

Researchers developed a method of identifying candidates with rheumatoid arthritis (RA) for dose reduction of disease modifying anti-rheumatic drugs (DMARDs). ----- Related Content Certolizumab combo helps curb RA...

...

06/19/2017

Journal of Clinical Pathways

Research in Review

Adding Targeted Therapy Improves CAR-T Response Rates in CLL

06/15/2017

JCP Editors

Researchers report significantly improved response rates in patients with chronic lymphocytic leukemia (CLL) treated with concurrent targeted therapy and chimeric antigen receptor T-cell (CAR-T)...

...

06/15/2017

Journal of Clinical Pathways

Research in Review

TKI Safe and Effective in Pediatric CML

06/15/2017

JCP Editors

A recent study demonstrated high response rates and tolerable safety profiles in pediatric patients with chronic myeloid leukemia (CML) after treatment with a tyrosine kinase inhibitor (TKI). ----- Related...

A...

06/15/2017

Journal of Clinical Pathways

Research in Review

Personalized Dosing More Cost-Effective for NSCLC Treatment

06/15/2017

JCP Editors

A recent budget analysis evaluated the costs, safety, and efficacy of personalized dosing compared with fixed dosing of standard-of-care treatment for non-small cell lung cancer, presented at the 2017 ASCO Annual...

A...

06/15/2017

Journal of Clinical Pathways